移植进展:将迈大步实现还是靠边际增益?
本文讨论移植领域五大未满足需求及过去50年在手术技术、免疫屏障检测、免疫抑制和感染预防方面的进展,并展望生物标志物监测排斥、无药耐受、缺血再灌注损伤、猪肾异种移植和自体再生肾脏组织五个可能改进方向。
要点
- 移植五大未满足需求:避免移植、地理可及性差异、供需不匹配、移植物与患者存活、免疫抑制不良反应。
- 过去50年在手术技术、免疫屏障检测、化学与生物免疫抑制、微生物感染预防四方面取得进展。
- 未来五个可能改进方向:排斥监测血液生物标志物、稳定耐受实现无药移植、消除缺血再灌注损伤、猪肾异种移植、自体再生有功能肾组织。
核心结论
- 移植领域进展由大步突破与边际增益共同推动,未来在五个主要方向存在进一步改善潜力。
研究设计与样本
- 综述类文章,讨论移植领域未满足需求、历史进展与未来方向。
主要发现
- 过去50年在手术技术、免疫屏障检测、化学与生物免疫抑制、微生物感染预防至少四个方面取得进展。
- 未来可能改进的五个领域包括排斥监测血液生物标志物、通过稳定耐受实现无药移植、消除缺血再灌注损伤影响、猪肾异种移植、自体再生有功能肾组织治疗晚期肾病。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A wish for progress in transplantation assumes that there are needs not met by the currently available therapy and that the barriers to resolving the problems can be surmounted. There are 5 major unmet needs: the potential to avoid transplantation either by prevention of disease or provision of an alternative to natural biological organ replacement; geographic heterogeneity of access to, and quality of, transplantation; availability of transplantation to those in need of it; survival of the patient and the transplant; and the avoidance of adverse effects of immunosuppression. During the past 50 years, there have been advances on at least 4 of these 5 fronts that illustrate the interplay of "big steps" and "marginal gains" in the following areas: surgical technique, testing the immunologic barriers, introduction of chemical and biological immunosuppression, and prophylaxis for microbial infections. The potential for further improvement comes in 5 major areas: blood biomarkers for monitoring of rejection, drug-free transplantation through the development of stable tolerance, eliminating the impact of ischemia-reperfusion injury, xenotransplantation of porcine kidneys, and finally, the possibility of autologous regeneration of functioning kidney tissue to treat advanced kidney disease.
引用
- Chapman JR. Progress in Transplantation: Will It Be Achieved in Big Steps or by Marginal Gains? Am J Kidney Dis. 2016. PMID: 27823818. doi:10.1053/j.ajkd.2016.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。